Immunomodulatory mechanisms of bile acids in autoimmune diseases along the gut-liver axis.
The immune-regulatory network of BAs, which includes both receptor-dependent pathways and receptor-independent mechanisms, is examined, and emerging therapeutic strategies aimed at restoring metabolic-immune homeostasis are assessed.